Source link : https://newshealth.biz/health-news/dupilumab-improves-esophageal-distensibility-in-eosinophilic-esophagitis/
The monoclonal antibody dupilumab (Dupixent) led to significant improvements in esophageal distensibility among patients with eosinophilic esophagitis, the randomized REMODEL trial showed. At 24 weeks, patients taking dupilumab had an absolute change in esophageal distensibility plateau diameter from baseline of 1.28 mm versus -0.01 mm in those receiving placebo (least squares mean [LSM] difference 1.30, […]
The post Dupilumab Improves Esophageal Distensibility in Eosinophilic Esophagitis first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-08 18:52:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8